Schedule 13D ownership disclosure
EYEGATE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 30233M503
Event date: 2021-01-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 56.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-21-000243
- Form type
- SC 13D
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Jan 12, 2021
- Reporting period
- Jan 06, 2021
- Description
- Schedule 13D beneficial ownership